Colin E Rowlings

Title: The Innovative Contributions of Colin E Rowlings

Introduction

Colin E Rowlings is a notable inventor based in Potomac, Indiana, who has made significant contributions to the field of pharmaceuticals. With a total of eight patents to his name, Rowlings has focused on developing innovative antibiotic products and delivery systems that enhance the efficacy of medications.

Latest Patents

Among his latest patents is an antibiotic product that features at least three dosage forms, each designed with a different release profile. This innovative formulation ensures that the concentration of the antibiotic reaches therapeutic levels in less than twelve hours after the initial release. Additionally, Rowlings has developed a pharmaceutical tablet for pulsed delivery, which includes an immediate release portion and a delayed release portion. The delayed release portion is equipped with an enteric-coated layer, containing either enteric-coated microparticle dosage forms or mini-tablet dosage forms, both of which contain active ingredients.

Career Highlights

Colin E Rowlings has established himself as a key figure in pharmaceutical innovation through his work at Shionogi, Inc. His expertise in drug formulation and delivery systems has positioned him as a valuable asset in the industry. Rowlings' patents reflect his commitment to improving patient outcomes through advanced pharmaceutical technologies.

Collaborations

Rowlings has collaborated with several professionals in his field, including Beth A Burnside and Henry H Flanner. These partnerships have contributed to the development of his innovative products and have fostered a collaborative environment for research and development.

Conclusion

Colin E Rowlings exemplifies the spirit of innovation in the pharmaceutical industry through his groundbreaking patents and collaborative efforts. His work continues to impact the field positively, paving the way for more effective treatments.